These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24022755)

  • 21. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
    Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
    Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance.
    Rosales-Aviña JA; Torres-Flores J; Aguilar-Lemarroy A; Gurrola-Díaz C; Hernández-Flores G; Ortiz-Lazareno PC; Lerma-Díaz JM; de Celis R; González-Ramella Ó; Barrera-Chaires E; Bravo-Cuellar A; Jave-Suárez LF
    J Exp Clin Cancer Res; 2011 Dec; 30(1):112. PubMed ID: 22185299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and analysis of conserved cis-regulatory regions of the MEIS1 gene.
    Royo JL; Bessa J; Hidalgo C; Fernández-Miñán A; Tena JJ; Roncero Y; Gómez-Skarmeta JL; Casares F
    PLoS One; 2012; 7(3):e33617. PubMed ID: 22448256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon.
    Spieler D; Kaffe M; Knauf F; Bessa J; Tena JJ; Giesert F; Schormair B; Tilch E; Lee H; Horsch M; Czamara D; Karbalai N; von Toerne C; Waldenberger M; Gieger C; Lichtner P; Claussnitzer M; Naumann R; Müller-Myhsok B; Torres M; Garrett L; Rozman J; Klingenspor M; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Beckers J; Hölter SM; Meitinger T; Hauck SM; Laumen H; Wurst W; Casares F; Gómez-Skarmeta JL; Winkelmann J
    Genome Res; 2014 Apr; 24(4):592-603. PubMed ID: 24642863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.
    Hess JL; Bittner CB; Zeisig DT; Bach C; Fuchs U; Borkhardt A; Frampton J; Slany RK
    Blood; 2006 Jul; 108(1):297-304. PubMed ID: 16507773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.
    Sun Y; Zhou B; Mao F; Xu J; Miao H; Zou Z; Phuc Khoa LT; Jang Y; Cai S; Witkin M; Koche R; Ge K; Dressler GR; Levine RL; Armstrong SA; Dou Y; Hess JL
    Cancer Cell; 2018 Oct; 34(4):643-658.e5. PubMed ID: 30270123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation.
    Mamo A; Krosl J; Kroon E; Bijl J; Thompson A; Mayotte N; Girard S; Bisaillon R; Beslu N; Featherstone M; Sauvageau G
    Blood; 2006 Jul; 108(2):622-9. PubMed ID: 16469876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations.
    Quentmeier H; Dirks WG; Macleod RA; Reinhardt J; Zaborski M; Drexler HG
    Leuk Lymphoma; 2004 Mar; 45(3):567-74. PubMed ID: 15160920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines.
    Wermuth PJ; Buchberg AM
    Blood; 2005 Feb; 105(3):1222-30. PubMed ID: 15479723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The deficiency of tumor suppressor prep1 accelerates the onset of meis1- hoxa9 leukemogenesis.
    Dardaei L; Modica L; Iotti G; Blasi F
    PLoS One; 2014; 9(5):e96711. PubMed ID: 24809472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
    Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
    Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The TALE homeodomain transcription factor MEIS1 activates the pro-metastatic melanoma cell adhesion molecule Mcam to promote migration of pancreatic cancer cells.
    von Burstin J; Bachhuber F; Paul M; Schmid RM; Rustgi AK
    Mol Carcinog; 2017 Mar; 56(3):936-944. PubMed ID: 27583552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
    Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
    Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.
    Rozovskaia T; Feinstein E; Mor O; Foa R; Blechman J; Nakamura T; Croce CM; Cimino G; Canaani E
    Oncogene; 2001 Feb; 20(7):874-8. PubMed ID: 11314021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis.
    Yokoyama T; Nakatake M; Kuwata T; Couzinet A; Goitsuka R; Tsutsumi S; Aburatani H; Valk PJ; Delwel R; Nakamura T
    J Clin Invest; 2016 May; 126(5):1664-78. PubMed ID: 27018596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.
    Pineault N; Helgason CD; Lawrence HJ; Humphries RK
    Exp Hematol; 2002 Jan; 30(1):49-57. PubMed ID: 11823037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
    Schneider E; Staffas A; Röhner L; Malmberg ED; Ashouri A; Krowiorz K; Pochert N; Miller C; Wei SY; Arabanian L; Buske C; Döhner H; Bullinger L; Fogelstrand L; Heuser M; Döhner K; Xiang P; Ruschmann J; Petriv OI; Heravi-Moussavi A; Hansen CL; Hirst M; Humphries RK; Rouhi A; Palmqvist L; Kuchenbauer F
    Haematologica; 2018 Feb; 103(2):246-255. PubMed ID: 29217774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditionally immortalised leukaemia initiating cells co-expressing Hoxa9/Meis1 demonstrate microenvironmental adaptation properties ex vivo while maintaining myelomonocytic memory.
    Stahlhut M; Ha TC; Takmakova E; Morgan MA; Schwarzer A; Schaudien D; Eder M; Schambach A; Kustikova OS
    Sci Rep; 2021 Mar; 11(1):5294. PubMed ID: 33674652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.